Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications

V Yank, CV Tuohy, AC Logan, DM Bravata… - Annals of internal …, 2011 - acpjournals.org
Background: Recombinant factor VIIa (rFVIIa), a hemostatic agent approved for hemophilia,
is increasingly used for off-label indications. Purpose: To evaluate the benefits and harms of …

Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study

V Yank, D Rennie, LA Bero - Bmj, 2007 - bmj.com
Objective To determine whether financial ties to one drug company are associated with
favourable results or conclusions in meta-analyses on antihypertensive drugs. Design …

When authorship fails: a proposal to make contributors accountable

D Rennie, V Yank, L Emanuel - Jama, 1997 - jamanetwork.com
A published article is the primary means whereby new work is communicated, priority is
established, and academic promotion is determined. Publication depends on trust and …

Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial

J Ma, V Yank, L Xiao, PW Lavori, SR Wilson… - JAMA internal …, 2013 - jamanetwork.com
Background The Diabetes Prevention Program (DPP) lifestyle intervention reduced the
incidence of type 2 diabetes mellitus (DM) among high-risk adults by 58%, with weight loss …

Disclosure of Researcher Contributions: A Study of Original Research Articles in The Lancet

V Yank, D Rennie - Annals of internal medicine, 1999 - acpjournals.org
Background: Authorship disputes and abuses have increased in recent years. In response to
a proposal that researcher contributions be specified for readers, The Lancet began …

Prevalence of honorary and ghost authorship in Cochrane reviews

…, JM Grimshaw, D Rennie, A Flanagin, V Yank… - Jama, 2002 - jamanetwork.com
ContextTo determine the prevalence of honorary and ghost authorship in Cochrane reviews,
how authorship is assigned, and the ways in which authors and Cochrane editorial teams …

Off-label use of recombinant factor VIIa in US hospitals: analysis of hospital records

AC Logan, V Yank, RS Stafford - Annals of Internal Medicine, 2011 - acpjournals.org
Background: Recombinant factor VIIa (rFVIIa) is approved for treatment of bleeding in
patients who have hemophilia with inhibitors but has been applied to a wide range of off …

The contributions of authors

D Rennie, A Flanagin, V Yank - Jama, 2000 - jamanetwork.com
4. Bruster S, Jarman B, Bosanquet N, Weston D, Erens R, Delbanco TL. National survey of
hospital patients. BMJ. 1994; 309: 1542-1546. 5. Quill TE, Dresser R, Brock DW. The rule of …

Reporting of informed consent and ethics committee approval in clinical trials

V Yank, D Rennie - Jama, 2002 - jamanetwork.com
ContextTo determine whether journals have improved their disclosure of ethical protections
in clinical trials. MethodsComparison of clinical trials published before and after 1997 (July …

Effect of structured, moderate exercise on kidney function decline in sedentary older adults: an ancillary analysis of the LIFE study randomized clinical trial

…, RS Stafford, LA Pruitt, K Berra, V Yank… - JAMA internal …, 2022 - jamanetwork.com
Importance Observational evidence suggests that higher physical activity is associated with
slower kidney function decline; however, to our knowledge, no large trial has evaluated …